Texas AG Ken Paxton Sues Tylenol for Alleged Autism Risks
Texas Attorney General Ken Paxton has initiated legal action against Johnson & Johnson and its consumer products affiliate Kenvue. The lawsuit centers on allegations of deceptive marketing concerning the popular pain reliever Tylenol, specifically targeting its promotion to pregnant women.
Allegations of Deceptive Marketing
Paxton contends that the companies failed to disclose potential risks associated with Tylenol, particularly the alleged link to autism in unborn children. This claim emerges despite the absence of conclusive evidence directly connecting acetaminophen to autism or ADHD (attention-deficit/hyperactivity disorder).
Research and Studies Cited
- The complaint references notable studies, including the Nurses’ Health Study II and the Boston Birth Cohort.
- These studies have suggested possible correlations between prenatal acetaminophen usage and developmental disorders.
Violations of Texas Law
According to Paxton, Johnson & Johnson engaged in unlawful practices by transferring liabilities associated with Tylenol to Kenvue, which he claims was an attempt to evade responsibilities tied to potential lawsuits.
Comments from Ken Paxton
In his statement, Paxton expressed his concerns about the actions of large pharmaceutical companies, asserting that they prioritize profit over public health. He stated, “Big Pharma betrayed America by profiting off of pain and pushing pills regardless of the risks.”
Response from Kenvue
Kenvue issued a rebuttal to the lawsuit, characterizing the allegations as a significant misrepresentation of the facts. The company emphasized its commitment to health and safety, affirming, “Nothing is more important to us than the health and safety of the people who use our products.”
Regulatory Standpoint
The U.S. Food and Drug Administration (FDA) has clarified that there is no established causal link between Tylenol and neurological disorders. Additionally, the FDA regards acetaminophen as the only over-the-counter medication deemed safe for fever treatment during pregnancy, whereas other common medications like aspirin and ibuprofen may present risks to a developing fetus.
This ongoing case underscores the complexities of pharmaceutical liability and the scrutiny faced by drug manufacturers in the current healthcare landscape.
